Cargando…
The effect of select systemic medications on outcomes in diabetics with central retinal vein occlusion
BACKGROUND: Diabetes mellitus is a risk factor for central retinal vein occlusion (CRVO); however, it is unclear whether certain commonly used medications among diabetics or glycemic control impact visual outcomes in diabetic eyes with CRVO. PURPOSE: To evaluate the effect of select systemic medicat...
Autores principales: | Simmons, Kirsten, Singh, Pali, Borkar, Durga S., Birnbaum, Faith, Thomas, Akshay S., Fekrat, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785328/ https://www.ncbi.nlm.nih.gov/pubmed/35083418 http://dx.doi.org/10.1177/25158414211063076 |
Ejemplares similares
-
Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion
por: Singh, Pali P., et al.
Publicado: (2021) -
Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
por: Oellers, Patrick, et al.
Publicado: (2016) -
Branch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
por: Moradian, Siamak, et al.
Publicado: (2009) -
Longitudinal Assessment of the Choroidal Vascularity Index in Eyes with Branch Retinal Vein Occlusion-Associated Cystoid Macular Edema
por: Pant, Praruj, et al.
Publicado: (2023) -
Central retinal vein occlusion and branch retinal vein occlusion in the same eye
por: Sundar, M Dheepak, et al.
Publicado: (2019)